FDA OKs testing Aethlon Ebola device

January 2, 2015 3:23 PM

4 0

The Hemopurifier was recently used on an emergency basis in Germany on an Ebola patient treated there. The patient, a Ugandan doctor who was treating Ebola patients in Sierra Leone, recovered. However, that case doesn't prove the Hemopurifier helped the recovery. The FDA-approved clinical trial is intended to look for such evidence.

The FDA's approval allows a trial at up to 10 U.S. clinical sites. Up to 20 U.S. subjects may be enrolled to receive the treatment. Patients will get daily Hemopurifier blood filtration for six to eight hours until the Ebola viral load drops below 1,000 virus copies per milliliter of blood. The Ugan...

Also read: U.S. FDA approves St. Jude device to cut stroke risk

Read more

To category page